INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo ENZYNORM tablets
SCHEDULING STATUS
S1

PROPRIETARY NAME
(and dosage form):

ENZYNORM tablets

COMPOSITION
Per tablet:
Cathepsin and pepsin and protein-bound hydrochloric acid
One tablet is equivalent to 8,75 pepsin units.

PHARMACOLOGICAL CLASSIFICATION
A 11.1 Digestants

PHARMACOLOGICAL ACTION
ENZYNORM contains the two proteolytic enzymes, pepsin and cathepsin and protein-bound hydrochloric acid, which is slowly liberated in the stomach so that a sudden change of acidity is avoided. The powdered extract of the healthy gastric mucosa acts as a buffer and its components, as biological carriers of hydrochloric acid, stimulate the formation of gastrin in the gastric mucous membrane. The production of gastric juice is thereby strongly increased in a physiological way, provided that intact gastric glandular tissue still exists.
The decomposition products of low molecular weight formed in the proteolytic degradation of protein also have a secretion-promoting effect thus activating the process of digestion. At the same time the physiological increase of the gastric juice acidity produces a pH environment favourable to the proteases of the stomach. The combined effect, consisting of substitution and stimulation, ensures that ENZYNORM completely eliminates any gastric enzyme deficiency and thus restores the normal function of the stomach in a natural way.
ENZYNORM is proteolytically active within the entire pH-range of the stomach. Because of the cathepsin activity, ENZYNORM exercises its digestive function even in a faintly acid milieu such as exists at the beginning of a meal. Furthermore, there is no risk of over acidification, since the protein-bound hydrochloric acid is only released until the normal pH of the stomach is reached.
Properties include the following:
Supplements insufficient acids and enzymes in the stomach.
Restores the normal digestive function.
Relieves digestive disturbances.
Stimulates the production of the stomach's own juices.
Diagnostic aid between hypo- and hyperacidity

INDICATIONS
Digestive disturbances in general and as a result of impaired production of gastric juice
After gastric resection and in gastritis
Conditions of unexplained anaemias in most cases of hypochromic nature
To improve the appetite and as an adjunct in the treatment of anaemic conditions, especially in children During slimming diet when protein intake increases

CONTRA-INDICATIONS
None known to date

DOSAGE AND DIRECTIONS FOR USE
ENZYNORM can be used for an unlimited period without side-effects.
The usual dose is one to three tablets three times a day before meals.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS
Side-effects: none known to date
Special precautions: not applicable

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT
None known
Does not contain any substances which could cause intoxication.

IDENTIFICATION
Yellow, coated tablet

PRESENTATION
Tablets: 50', 250' and 500'

STORAGE INSTRUCTIONS
Store below 25°C in a dry place
KEEP OUT OF REACH OF CHILDREN.

REFERENCE NUMBER
E934 (Act 101/1965)

NAME AND BUSINESS ADDRESS OF THE APPLICANT
NORISTAN LIMITED
326 MARKS STREET, WALTLOO, PRETORIA

DATE OF PUBLICATION OF THIS PACKAGE INSERT
24 August 1972

NORISTAN LABORATORIES
Division of
NORISTAN LIMITED, WALTLOO, PRETORIA
Under licence to Nordmark-Werke GmbH, Hamburg, Germany

        D176/011

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2000